Armistice Capital, LLC Prothena Corp Public LTD CO Transaction History
Armistice Capital, LLC
- $6.51 Billion
- Q3 2025
A detailed history of Armistice Capital, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Armistice Capital, LLC holds 1,824,000 shares of PRTA stock, worth $18.7 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
1,824,000
Previous 2,236,000
18.43%
Holding current value
$18.7 Million
Previous $13.6 Million
31.17%
% of portfolio
0.27%
Previous 0.24%
Shares
8 transactions
Others Institutions Holding PRTA
# of Institutions
217Shares Held
34.9MCall Options Held
656KPut Options Held
1.12M-
Black Rock Inc. New York, NY3.86MShares$39.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$21 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY1.54MShares$15.8 Million0.25% of portfolio
-
Adar1 Capital Management, LLC Austin, TX1.47MShares$15.1 Million1.35% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.32MShares$13.6 Million2.57% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $481M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...